Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis

Background: Sorafenib has been recommended as the standard therapy for advanced HCC with extrahepatic metastasis. The purpose of this retrospective study was to investigate the difference in overall survival (OS) between treatments with sorafenib combined with regional therapies versus sorafenib mon...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Cancer
Huvudupphovsmän: Chen, Jinbin, Lu, Shixun, Zhang, Yaojun, Xu, Li, Chen, Jiancong, Wang, Juncheng, Chen, Minshan, Zhang, Rongxin, Zhou, Zhongguo
Materialtyp: Artigo
Språk:Inglês
Publicerad: Ivyspring International Publisher 2018
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5968762/
https://ncbi.nlm.nih.gov/pubmed/29805700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.24568
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk